SEC Info - Colfax Corp - ‘10-K’ for 12/31/15

SEC Info℠

Home

Help

Please Sign In

Colfax Corp – ‘10-K’ for 12/31/15 – ‘EX-10.37’

On: Tuesday, 2/16/16, at 4:24pm ET · For: 12/31/15 · Accession #: 1420800-16-47 · File #: 1-34045

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/16/16  Colfax Corp                       10-K       12/31/15  116:17M

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.36M 
 2: EX-10.15    Material Contract                                   HTML    175K 
 3: EX-10.37    Material Contract                                   HTML     44K 
 4: EX-21.1     Subsidiaries List                                   HTML     78K 
 5: EX-23.1     Consent of Experts or Counsel                       HTML     31K 
 6: EX-31.01    Certification -- §302 - SOA'02                      HTML     38K 
 7: EX-31.02    Certification -- §302 - SOA'02                      HTML     38K 
 8: EX-32.01    Certification -- §906 - SOA'02                      HTML     32K 
 9: EX-32.02    Certification -- §906 - SOA'02                      HTML     32K 
16: R1          Document and Entity Information                     HTML     59K 
17: R2          Consolidated Statements of Income                   HTML     80K 
18: R3          Consolidated Statements of Comprehensive (Loss)     HTML     65K 
                Income                                                           
19: R4          Consolidated Statements of Comprehensive (Loss)     HTML     41K 
                Income [Parenthetical]                                           
20: R5          Consolidated Balance Sheets                         HTML    107K 
21: R6          Consolidated Balance Sheets [Parenthetical]         HTML     41K 
22: R7          Consolidated Statements of Equity                   HTML    116K 
23: R8          Consolidated Statements of Equity Consolidated      HTML     39K 
                Statements of Equity [Parenthetical]                             
24: R9          Consolidated Statements of Cash Flows               HTML    122K 
25: R10         General                                             HTML     35K 
26: R11         Summary of Significant Accounting Policies          HTML    116K 
                Accounting Policies                                              
27: R12         Recently Issued Accounting Pronouncements           HTML     43K 
28: R13         Acquisitions                                        HTML     82K 
29: R14         Net Income Per Share                                HTML     73K 
30: R15         Income Taxes                                        HTML    138K 
31: R16         Goodwill & Intangibles                              HTML     87K 
32: R17         Property, Plant and Equipment, Net                  HTML     55K 
33: R18         Inventories, Net                                    HTML     45K 
34: R19         Debt                                                HTML     71K 
35: R20         Equity                                              HTML    271K 
36: R21         Accrued Liabilities                                 HTML    174K 
37: R22         Defined Benefit Plans                               HTML    532K 
38: R23         Financial Instruments and Fair Value Measurements   HTML    182K 
39: R24         Commitments and Contingencies                       HTML     94K 
40: R25         Segment Information                                 HTML    159K 
41: R26         Selected Quarterly Data - (Unaudited)               HTML     85K 
42: R27         Schedule II - Valuation and Qualifying Accounts     HTML     93K 
                (Notes)                                                          
43: R28         Summary of Significant Accounting Policies          HTML    175K 
                Accounting Policies (Policies)                                   
44: R29         Summary of Significant Accounting Policies          HTML     45K 
                Accounting Policies (Tables)                                     
45: R30         Acquisitions (Tables)                               HTML     55K 
46: R31         Net Income Per Share (Tables)                       HTML     67K 
47: R32         Income Taxes (Tables)                               HTML    132K 
48: R33         Goodwill & Intangibles (Tables)                     HTML     85K 
49: R34         Property, Plant and Equipment, Net (Tables)         HTML     51K 
50: R35         Inventories, Net (Tables)                           HTML     44K 
51: R36         Debt (Tables)                                       HTML     54K 
52: R37         Equity (Tables)                                     HTML    258K 
53: R38         Accrued Liabilities (Tables)                        HTML    176K 
54: R39         Defined Benefit Plans (Tables)                      HTML    539K 
55: R40         Financial Instruments and Fair Value Measurements   HTML    172K 
                (Tables)                                                         
56: R41         Commitments and Contingencies (Tables)              HTML     73K 
57: R42         Segment Information (Tables)                        HTML    157K 
58: R43         Selected Quarterly Data - (Unaudited) (Tables)      HTML     84K 
59: R44         Summary of Significant Accounting Policies          HTML     44K 
                Warranty Costs (Details)                                         
60: R45         Summary of Significant Accounting Policies          HTML    105K 
                Accounting Policies (Details Textual)                            
61: R46         Recently Issued Accounting Pronouncements           HTML     46K 
                (Details)                                                        
62: R47         Acquisitions Purchase Price Allocation (Details)    HTML     54K 
63: R48         Acquisitions (Details Textual)                      HTML    103K 
64: R49         Net Income Per Share (Details)                      HTML     68K 
65: R50         Net Income Per Share (Details Textual)              HTML     35K 
66: R51         Income Taxes Domestic and Foreign (Details)         HTML     67K 
67: R52         Income Taxes Reconciliation (Details)               HTML     51K 
68: R53         Income Taxes Deferred Tax Assets and Liabilities    HTML     64K 
                (Details)                                                        
69: R54         Income Taxes Gross Unrecognized Tax Benefits        HTML     43K 
                (Details)                                                        
70: R55         Income Taxes (Details Textual)                      HTML     67K 
71: R56         Goodwill & Intangibles Goodwill (Details)           HTML     46K 
72: R57         Goodwill & Intangibles Intangible Assets (Details)  HTML     50K 
73: R58         Goodwill & Intangibles Amortization Expense         HTML     33K 
                (Details)                                                        
74: R59         Goodwill & Intangibles (Details Textual)            HTML     41K 
75: R60         Property, Plant and Equipment, Net (Details)        HTML     63K 
76: R61         Property, Plant and Equipment, Net (Details         HTML     42K 
                Textual)                                                         
77: R62         Inventories, Net (Details)                          HTML     47K 
78: R63         Debt (Details)                                      HTML     44K 
79: R64         Debt Schedule of Debt Maturities (Details)          HTML     53K 
80: R65         Debt (Details Textual)                              HTML     94K 
81: R66         Equity (Details)                                    HTML     85K 
82: R67         Equity (Details 1)                                  HTML     59K 
83: R68         Equity Stock-based compensation (Details)           HTML     35K 
84: R69         Equity Option Valuation Assumptions (Details)       HTML     43K 
85: R70         Equity Option Award Activity (Details)              HTML     81K 
86: R71         Equity PRSU and RSU Activity (Details)              HTML     59K 
87: R72         Equity Textuals (Details)                           HTML     85K 
88: R73         Accrued Liabilities (Details)                       HTML     57K 
89: R74         Restructuring Rollforward (Details 1)               HTML     76K 
90: R75         Accrued Liabilities (Details Textual)               HTML     38K 
91: R76         Defined Benefit Plans Obligation and Asset          HTML    122K 
                Rollforward (Details)                                            
92: R77         Defined Benefit Plans Defined Benefit Expected      HTML     50K 
                Benefit Payments (Details)                                       
93: R78         Defined Benefit Plans Plan Asset Allocation         HTML     58K 
                (Details)                                                        
94: R79         Defined Benefit Plans Plan Asset Allocation, Fair   HTML     90K 
                Value Hierarchy (Details)                                        
95: R80         Defined Benefit Plans Net Periodic Benefit Cost     HTML     74K 
                (Details)                                                        
96: R81         Defined Benefit Plans Defined Benefit Plans,        HTML     49K 
                Accumulated Other Comprehensive Loss (Details)                   
97: R82         Defined Benefit Plans Key Economic Assumptions      HTML     49K 
                (Details)                                                        
98: R83         Defined Benefit Plans Health Care Assumption        HTML     39K 
                Effect (Details)                                                 
99: R84         Defined Benefit Plans Details Textual (Details)     HTML     55K 
100: R85         Fair Value Hierarchy (Details)                      HTML     63K  
101: R86         Notional Values (Details)                           HTML     37K  
102: R87         Gain (Loss) on Derivative Instruments (Details)     HTML     48K  
103: R88         Financial Instruments and Fair Value Measurements   HTML     33K  
                (Details Textual)                                                
104: R89         Claims Rollforward (Details)                        HTML     39K  
105: R90         Asbestos Litigation (Details 1)                     HTML     38K  
106: R91         Commitments and Contingencies Operating Lease       HTML     48K  
                (Details 2)                                                      
107: R92         Commitments and Contingencies (Details Textual)     HTML     58K  
108: R93         Segment Information (Details)                       HTML     80K  
109: R94         Segment Information Net Sales by Major Product      HTML     41K  
                (Details)                                                        
110: R95         Segment Information Net Sales and PPE by Geography  HTML     52K  
                (Details)                                                        
111: R96         Selected Quarterly Data - (Unaudited) (Details)     HTML     57K  
112: R97         Selected Quarterly Data - (Unaudited) (Details      HTML     38K  
                Textual)                                                         
113: R98         Schedule II - Valuation and Qualifying Accounts     HTML     60K  
                (Details)                                                        
115: XML         IDEA XML File -- Filing Summary                      XML    208K  
114: EXCEL       IDEA Workbook of Financial Reports                  XLSX    157K  
10: EX-101.INS  XBRL Instance -- cfx-20151231                        XML   6.11M 
12: EX-101.CAL  XBRL Calculations -- cfx-20151231_cal                XML    275K 
13: EX-101.DEF  XBRL Definitions -- cfx-20151231_def                 XML    853K 
14: EX-101.LAB  XBRL Labels -- cfx-20151231_lab                      XML   2.41M 
15: EX-101.PRE  XBRL Presentations -- cfx-20151231_pre               XML   1.39M 
11: EX-101.SCH  XBRL Schema -- cfx-20151231                          XSD    250K 
116: ZIP         XBRL Zipped Folder -- 0001420800-16-000047-xbrl      Zip    429K

‘EX-10.37’ — Material Contract

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

<! C: C:

Exhibit

AMENDMENT NO. 2 TO

COLFAX CORPORATION

REGISTRATION RIGHTS AGREEMENT

February 15, 2016

This Amendment No. 2 (this “Amendment”), dated as of February 15, 2016 (the “Effective Date”), to that certain Registration Rights Agreement (the “Agreement”), dated as of May 30, 2003, by and among Colfax Corporation, a Delaware corporation (the “Company”), and Mitchell P. Rales and Steven M. Rales (together, the “Rales Holders”) and the other Stockholders party thereto, as previously amended February 18, 2013, is made by and among the Company and the Rales Holders. Capitalized terms used herein without definition shall have the meanings given to such terms in the Agreement.

RECITALS:

WHEREAS, pursuant to Sections 3 and 5 of the Agreement, the Company has granted the Rales Holders certain registration rights (the “Registration Rights”) with respect to the Registrable Securities during the Registration Rights Period;

WHEREAS, the Registration Rights currently expire on May 8, 2016 (the “Amendment No. 1 Expiration Date”);

WHEREAS, the Rales Holders have agreed to refrain from exercising the Registration Rights prior to the Amendment No. 1 Expiration Date in consideration for the extension by the Company of the Registration Rights Period.

NOW, THEREFORE, in consideration of the mutual promises and covenants set forth herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:


1.	Amendment to Section 1. The definition of “Registration Rights Period” set forth in Section 1 of the Agreement is amended and restated in its entirety to read as follows:

“Registration Rights Period” means for purposes of the registration rights granted under Section 3 and Section 5 hereof, the period commencing on such date that is 180 days from the closing date of a Qualified Public Offering and ending on May 8, 2019.


2.	Amendment to Section 17. The notice provision set forth in Section 17 of the Agreement is amended and restated in its entirety to read as follows:

All notices, demands, requests, consents or other communications to be given or delivered under or by reason of the provisions of this Agreement shall be in writing and shall be deemed to have been given when (i) delivered personally to the recipient, (ii) sent by confirmed facsimile or confirmed electronic mail transmission before

5:00 p.m. New York City time on a Business Day, and otherwise on the next Business Day, or (iii) one Business Day after being sent to the recipient by reputable overnight courier service (charges prepaid). Such notices, demands, requests, consents and other communications shall be sent (i) if to the Company, to Colfax Corporation, 420 National Business Parkway, 5^th Floor, Annapolis Junction, MD 20701, facsimile number (301) 323-9001, and (ii) if to any Holder, to 2200 Pennsylvania Avenue, NW, Suite 800W, Washington, DC 20037, or to such Holder at the address then on record with the Company or to such other address of Holder designated in writing to the Company from time to time.


3.	Waiver of Registration Rights. The Rales Holders agree not to exercise the Registration Rights prior to the Amendment No. 1 Expiration Date.


4.	Continuing Effect. With the exception of this Amendment and the prior amendment to the Agreement, the remaining provisions of the Agreement remain unchanged.


5.	Interpretation of Amendment. In the event of any conflict, inconsistency or incongruity between any provision of this Amendment and any provision of the Agreement, the provisions of this Amendment shall govern and control.


6.	Counterparts. This Amendment may be executed in any number of counterparts, each of which shall be deemed to be an original and all of which together shall be deemed to be one and the same instrument.


7.	Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF DELAWARE WITHOUT GIVING EFFECT TO ITS PRINCIPLES OR RULES OF CONFLICT OF LAWS TO THE EXTENT SUCH PRINCIPLES OR RULES WOULD REQUIRE OR PERMIT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION.

[Signature page follows]

IN WITNESS WHEREOF, the parties have executed this Amendment as of the Effective Date set forth above.

COLFAX CORPORATION

By: /s/ MATTHEW L. TREROTOLA

Name: Matthew L. Trerotola

Title: President and CEO

[Amendment No. 2 to Registration Rights Agreement]

RALES HOLDERS

/s/ MITCHELL P. RALES

Mitchell P. Rales

/s/ STEVEN M. RALES

Steven M. Rales

[Amendment No. 2 to Registration Rights Agreement]

Dates Referenced Herein and Documents Incorporated by Reference

This ‘10-K’ Filing	Date	Other Filings

	5/8/19	10-Q, 8-K
	5/8/16
Filed on:	2/16/16	5, SC 13G, SC 13G/A
	2/15/16	4
For Period end:	12/31/15	11-K, 4, 5, SD
	2/18/13	4
	5/30/03
		List all Filings

7 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/22/24  Enovis Corp.                      10-K       12/31/23  123:15M
 3/01/23  Enovis Corp.                      10-K       12/31/22  124:18M
 2/22/22  Enovis Corp.                      10-K       12/31/21  129:18M
 2/18/21  Enovis Corp.                      10-K       12/31/20  129:19M
 5/26/16  SEC                               UPLOAD¶     9/09/17    1:36K  Enovis Corp.
 5/18/16  SEC                               UPLOAD¶     9/09/17    1:138K Enovis Corp.
 4/26/16  SEC                               UPLOAD¶     9/09/17    1:159K Enovis Corp.

↑Top

Filing Submission 0001420800-16-000047 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)